In 2019, Overweight and obesity were the sixth leading risk factor for death and disability [2]
IGF-1 LR3 directly stimulates these cells even without significant muscle damage
While top-line growth remains strong, a deeper dive reveals growing reliance on GLP-1 sales, softening core metrics, and signs of pressure beneath the surface
The stable, dormant powder is now an active, aqueous solution, and the countdown to degradation has officially begun
Common adverse reactions reported in over 5% of patients treated with semaglutide include: Nausea Vomiting Diarrhea Abdominal pain Constipation Call your healthcare provider immediately if you experience any signs of an allergic reaction, including wheezing, chest tightness, fever, itching, bad cough, blue skin color, severe behavioral problems, chest pain or pressure, fast heartbeat, severe dizziness, passing out, nervousness and excitability, severe headache, or fits or swelling of the face, lips, tongue, or throat, How to reduce semaglutide side effects Your provider may start your weekly injections at a low dose and gradually increase to the prescribed dosage to minimize potential side effects
